| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 237 | 2013 |
| Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence CR Fumaz, JA Munoz-Moreno, J Moltó, E Negredo, MJ Ferrer, G Sirera, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (5), 560-565, 2005 | 215 | 2005 |
| Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada K Robertson, C Bayon, JM Molina, P McNamara, C Resch, ... AIDS care 26 (12), 1555-1561, 2014 | 153 | 2014 |
| Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients JA Muñoz-Moreno, CR Fumaz, MJ Ferrer, A Prats, E Negredo, M Garolera, ... AIDS research and human retroviruses 24 (10), 1301-1307, 2008 | 142 | 2008 |
| Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection M Gonzalez-Garcia, MJ Ferrer, X Borras, JA Munoz-Moreno, C Miranda, ... AIDS and Behavior 18, 676-685, 2014 | 114 | 2014 |
| Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review JA Munoz-Moreno, CR Fumaz, MJ Ferrer, M González-García, J Moltó, ... Aids Rev 11 (2), 103-9, 2009 | 110 | 2009 |
| Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy AM Anderson, JA Muñoz-Moreno, D McClernon, RJ Ellis, D Cookson, ... The Journal of infectious diseases, jiw505, 2016 | 88 | 2016 |
| Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study JA Muñoz-Moreno, CR Fumaz, MJ Ferrer, A Tuldrà, T Rovira, C Viladrich, ... Aids Research and human retroviruses 23 (10), 1166-1175, 2007 | 86 | 2007 |
| Resilience, ageing, and quality of life in long-term diagnosed HIV-infected patients CR Fumaz, A Ayestaran, N Perez-Alvarez, JA Muñoz-Moreno, J Moltó, ... Aids Care 27 (11), 1396-1403, 2015 | 61 | 2015 |
| Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances E Negredo, C Higueras, X Adell, JC Martinez, E Martinez, J Puig, ... AIDS Patient Care & STDs 20 (12), 829-837, 2006 | 61 | 2006 |
| Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach E Negredo, J Moltó, JA Muñoz-Moreno, E Pedrol, E Ribera, P Viciana, ... Antiviral therapy 9 (3), 335-342, 2004 | 61 | 2004 |
| Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study L Mateu, C Tebe, C Loste, JR Santos, G Lladós, C López, ... The Lancet Regional Health–Europe 33, 2023 | 60 | 2023 |
| Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints M Ariza, N Cano, B Segura, A Adan, N Bargalló, X Caldú, A Campabadal, ... Frontiers in aging neuroscience 14, 1029842, 2022 | 59 | 2022 |
| Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment CR Fumaz, M Gonzalez-Garcia, X Borras, JA Muñoz-Moreno, ... Brain, behavior, and immunity 26 (4), 568-572, 2012 | 54 | 2012 |
| Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs CR Fumaz, JA Muñoz-Moreno, J Molto, MJ Ferrer, R López-Blázquez, ... AIDS care 20 (7), 796-805, 2008 | 53 | 2008 |
| A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen JA Muñoz-Moreno, A Prats, N Pérez-Álvarez, CR Fumaz, M Garolera, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (5), 585-592, 2013 | 48 | 2013 |
| Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients CR Fumaz, JA Munoz-Moreno, AL Ballesteros, R Paredes, MJ Ferrer, ... AIDS care 19 (1), 138-145, 2007 | 42 | 2007 |
| Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART A Bonjoch, R Paredes, J Galvez, C Miralles, S Videla, E Martínez, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (3), 313-316, 2005 | 39 | 2005 |
| Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy E Negredo, J Puig, D Aldea, M Medina, C Estany, N Pérez-Álvarez, ... AIDS research and human retroviruses 25 (4), 451-455, 2009 | 36 | 2009 |
| Assessment of neurocognitive functions, olfaction, taste, mental, and psychosocial health in COVID-19 in adults: Recommendations for harmonization of research and implications … LA Cysique, E Łojek, TCK Cheung, B Cullen, AR Egbert, J Evans, ... Journal of the International Neuropsychological Society 28 (6), 642-660, 2022 | 35 | 2022 |
